FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia

This article was originally published here

The FDA initially approved Zerbaxa in 2014 to treat complicated intra-abdominal infections and for complicated urinary tract infections. “A key global challenge we face as a public health

The post FDA approves new treatment for hospital-acquired and ventilator-associated bacterial pneumonia appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply